| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/TOXSCI/KFW018 |
| P698 | PubMed publication ID | 26980302 |
| P2093 | author name string | Brian N Chorley | |
| Charlene A McQueen | |||
| Michelle M Angrish | |||
| Jonathan Phillip Kaiser | |||
| P2860 | cites work | Minireview: the case for obesogens | Q24641886 |
| Endocrine disrupters as obesogens | Q24647272 | ||
| Toxicant-associated steatohepatitis | Q27687049 | ||
| Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment | Q27921845 | ||
| Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling | Q28239680 | ||
| Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma | Q38447648 | ||
| Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells | Q39578297 | ||
| The nuclear receptor LXR is a glucose sensor | Q40190911 | ||
| Roles of Acyl-CoA:Diacylglycerol Acyltransferases 1 and 2 in Triacylglycerol Synthesis and Secretion in Primary Hepatocytes | Q41189971 | ||
| Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines | Q41515973 | ||
| Peroxisome proliferator-activated receptor alpha target genes. | Q42414964 | ||
| Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling | Q42440719 | ||
| Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome | Q44385945 | ||
| Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of L | Q44429399 | ||
| Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms | Q44832224 | ||
| Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome | Q46458713 | ||
| Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis | Q46870199 | ||
| Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk. | Q51686463 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis | Q28508851 | ||
| Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices | Q28539289 | ||
| Toxicant-associated steatohepatitis in vinyl chloride workers | Q33606531 | ||
| PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease | Q33734125 | ||
| In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project | Q33789756 | ||
| Synthesis and function of hepatic very-low-density lipoprotein | Q33975367 | ||
| A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis | Q34023100 | ||
| Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion | Q34651716 | ||
| Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis | Q34817393 | ||
| Adverse outcome pathway (AOP) development I: strategies and principles | Q35055206 | ||
| Adverse outcome pathway development II: best practices. | Q35055209 | ||
| Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model | Q35112180 | ||
| Identification of Environmental Chemicals Associated with the Development of Toxicant-associated Fatty Liver Disease in Rodents | Q35345024 | ||
| Aryl hydrocarbon receptor-mediated induction of Stearoyl-CoA desaturase 1 alters hepatic fatty acid composition in TCDD-elicited steatosis | Q35550990 | ||
| Regulation of stearoyl-CoA desaturases and role in metabolism | Q35599793 | ||
| Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. | Q35974420 | ||
| Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents | Q36183590 | ||
| Dietary fat is a lipid source in 2,3,7,8-tetrachlorodibenzo-ρ-dioxin (TCDD)-elicited hepatic steatosis in C57BL/6 mice | Q36383651 | ||
| TCDD-elicited effects on liver, serum, and adipose lipid composition in C57BL/6 mice | Q36509031 | ||
| The roles of nuclear receptors CAR and PXR in hepatic energy metabolism | Q37096480 | ||
| Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders. | Q37391109 | ||
| Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5) and adipose triglyceride lipase (Atgl). | Q37454139 | ||
| Liver X receptor in cholesterol metabolism | Q37616915 | ||
| Fatty liver and lipotoxicity | Q37621647 | ||
| The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. | Q37657815 | ||
| Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease | Q37677929 | ||
| Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism | Q37775728 | ||
| Current understanding of fatty acid biosynthesis and the acyl carrier protein | Q37775996 | ||
| Microsomal triglyceride transfer protein and nonalcoholic fatty liver disease | Q37863138 | ||
| Assembly and secretion of hepatic very-low-density lipoprotein | Q37925488 | ||
| Natural modulators of liver X receptors | Q38199226 | ||
| In vitro and modelling approaches to risk assessment from the U.S. Environmental Protection Agency ToxCast programme | Q38200703 | ||
| Modes-of-Action Related to Repeated Dose Toxicity: Tissue-Specific Biological Roles of PPAR γ Ligand-Dependent Dysregulation in Nonalcoholic Fatty Liver Disease. | Q38207591 | ||
| Gene expression in human NAFLD. | Q38292078 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatotoxicity | Q1349821 |
| P304 | page(s) | 261-268 | |
| P577 | publication date | 2016-03-15 | |
| P1433 | published in | Toxicological Sciences | Q2446966 |
| P1476 | title | Tipping the Balance: Hepatotoxicity and the 4 Apical Key Events of Hepatic Steatosis | |
| P478 | volume | 150 |
| Q38679066 | Advancing the adverse outcome pathway framework-An international horizon scanning approach |
| Q51150754 | Adverse Outcome Pathway Networks I: Development and Applications. |
| Q47865382 | Applying 'omics technologies in chemicals risk assessment: Report of an ECETOC workshop. |
| Q92287166 | Building and Applying Quantitative Adverse Outcome Pathway Models for Chemical Hazard and Risk Assessment |
| Q47807772 | Editor's Highlight: Mechanistic Toxicity Tests Based on an Adverse Outcome Pathway Network for Hepatic Steatosis |
| Q90722120 | Effect of perfluorooctanesulfonic acid (PFOS) on the liver lipid metabolism of the developing chicken embryo |
| Q88962279 | Effects of perfluorooctane sulfonate on genes controlling hepatic fatty acid metabolism in livers of chicken embryos |
| Q57296796 | Hepatic signalling disruption by pollutant Polychlorinated biphenyls in steatohepatitis |
| Q38941605 | Lipidomic Evaluation of Aryl Hydrocarbon Receptor-Mediated Hepatic Steatosis in Male and Female Mice Elicited by 2,3,7,8-Tetrachlorodibenzo-p-dioxin. |
| Q29248099 | Metabolism Disrupting Chemicals and Metabolic Disorders |
| Q38723141 | Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis |
| Q47187755 | Polychlorinated biphenyls disrupt hepatic epidermal growth factor receptor signaling |
| Q97519239 | Use of computational toxicology (CompTox) tools to predict in vivo toxicity for risk assessment |
Search more.